Otherwise, apoA-I or HDLs isolated from patients with T2D have a reduced capacity to inhibit the release of pro-inflammatory cytokines such as TNF-α and IL-1β by macrophages after lipopolysaccharide stimulation [100,101,107]. Here, APOA1 is linked to type 2 diabetes mellitus.